These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33669447)

  • 1. Ym155 Induces Oxidative Stress-Mediated DNA Damage and Cell Cycle Arrest, and Causes Programmed Cell Death in Anaplastic Thyroid Cancer Cells.
    Xu Q; Mackay RP; Xiao AY; Copland JA; Weinberger PM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site.
    Mackay RP; Weinberger PM; Copland JA; Mahdavian E; Xu Q
    Mol Cancer Ther; 2022 Jun; 21(6):925-935. PubMed ID: 35405742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer.
    Mehta A; Zhang L; Boufraqech M; Liu-Chittenden Y; Zhang Y; Patel D; Davis S; Rosenberg A; Ylaya K; Aufforth R; Li Z; Shen M; Kebebew E
    Clin Cancer Res; 2015 Sep; 21(18):4123-32. PubMed ID: 25944801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma.
    Chai J; Su M; Zhang R; Li N; Jia Y; Zheng W; Tan J; Jia Q; Sun H; Meng Z
    BMC Cancer; 2024 Jul; 24(1):816. PubMed ID: 38977966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling.
    Xu T; Zhang W; Zhang Y; Song F; Huang P
    J Cell Mol Med; 2024 Aug; 28(16):e70014. PubMed ID: 39153211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
    Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
    Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells
    Jo S; Ha TK; Han SH; Kim ME; Jung I; Lee HW; Bae SK; Lee JS
    Anticancer Res; 2017 Apr; 37(4):1705-1710. PubMed ID: 28373432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
    Hu Y; Wen Q; Cai Y; Liu Y; Ma W; Li Q; Song F; Guo Y; Zhu L; Ge J; Zeng Q; Wang J; Yin C; Zheng G; Ge M
    Phytomedicine; 2023 Jan; 108():154528. PubMed ID: 36343549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.
    Zhang L; Boufraqech M; Lake R; Kebebew E
    Oncotarget; 2016 Mar; 7(13):16517-28. PubMed ID: 26934320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
    Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
    Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.
    Weinlander E; Somnay Y; Harrison AD; Wang C; Cheng YQ; Jaskula-Sztul R; Yu XM; Chen H
    J Surg Res; 2014 Jul; 190(1):191-7. PubMed ID: 24679699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression.
    Chatterjee S; Rhee Y; Chung PS; Ge RF; Ahn JC
    J Photochem Photobiol B; 2018 Feb; 179():46-53. PubMed ID: 29331658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair.
    Qin Q; Cheng H; Lu J; Zhan L; Zheng J; Cai J; Yang X; Xu L; Zhu H; Zhang C; Liu J; Ma J; Zhang X; Dai S; Sun X
    J Hematol Oncol; 2014 Aug; 7():62. PubMed ID: 25139395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway.
    Chang BH; Johnson K; LaTocha D; Rowley JS; Bryant J; Burke R; Smith RL; Loriaux M; Müschen M; Mullighan C; Druker BJ; Tyner JW
    J Hematol Oncol; 2015 Apr; 8():39. PubMed ID: 25895498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer.
    Wang Y; Hu Z; Ma W; Niu Y; Su J; Zhang L; Zhao P
    Invest New Drugs; 2021 Jun; 39(3):764-774. PubMed ID: 33245464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juglone-ascorbic acid synergy inhibits metastasis and induces apoptotic cell death in poorly differentiated thyroid carcinoma by perturbing SOD and catalase activities.
    Gaikwad S; Chakraborty A; Salwe S; Patel V; Kulkarni S; Banerjee S
    J Biochem Mol Toxicol; 2018 Sep; 32(9):e22176. PubMed ID: 29992683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
    Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
    Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl trisulfide induces G2/M cell-cycle arrest and apoptosis in anaplastic thyroid carcinoma 8505C cells.
    Zheng J; Cheng X; Xu S; Zhang L; Pan J; Yu H; Bao J; Lu R
    Food Funct; 2019 Nov; 10(11):7253-7261. PubMed ID: 31617531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.
    Reeb AN; Li W; Sewell W; Marlow LA; Tun HW; Smallridge RC; Copland JA; Spradling K; Chernock R; Lin RY
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E232-42. PubMed ID: 25423568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.